Skip to main content
Fig. 4 | EJNMMI Research

Fig. 4

From: Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients

Fig. 4

[18F]AlF-OC (from left to right, clockwise: maximum-intensity projection PET, diffusion-weighted imaging (DWI b = 800) MRI and tilted transvere PET) and [68Ga]Ga-DOTATATE images (from left to right, counterclockwise: maximum-intensity projection PET, transversal PET, and fused PET-CT images) of a 65-year-old male patient with a NET with brain, bone, liver, and lymph node metastases. The transverse slices were tilted to illustrate more lesions in 1 slice. All [18F]AlF-OC have a corresponding lesion on DWI MRI. The light blue arrow indicates the primary lesion in the tail of the pancreas, the blue arrows indicate two liver metastases, and the red arrow indicates a bone metastasis. All lesions were also visible with [68Ga]Ga-DOTATATE (i.e., concordant lesions)

Back to article page